
Loading, please wait...

Loading, please wait...

Ayushman Bharat cancer coverage is a cornerstone of India's healthcare strategy, offering a vital lifeline for thousands of oncology patients. Notably, the scheme has provided financial protection for over 68 lakh treatments since its inception in 2018. Consequently, rural and low-income populations have gained access to advanced targeted therapies that were once out of reach. A study in The Lancet highlights that enrollment increases the chance of starting treatment within 30 days by 90%.
Despite these gains, a significant gap remains between current funding and the actual cost of standard care. Specifically, the FinCan study led by Dr. Abhishek Shankar from AIIMS Delhi reveals a substantial annual funding deficit. While the scheme currently allocates approximately Rs 7,700 crore for oncology, the full standard of care requires an estimated Rs 33,000 crore. Therefore, experts advocate for smarter spending to maximize the impact of every rupee. Furthermore, expediting diagnosis and treatment initiation could save Rs 1,500 crore and over 1,500 lives annually.
One major recommendation involves replacing the annual Rs 5 lakh cap with a five-year revolving ceiling of Rs 25 lakh. This reform would allow families to use more funds during high-cost periods, like the initial year of surgery. Additionally, the study supports a Rs 10 lakh top-up for high-stage cancers requiring expensive specialized interventions. Integrating diagnostics into the main scheme is also critical, as they currently represent only 3% of care costs. Lastly, the 2025-26 Union Budget has earmarked funds for 200 new day care cancer centers to further decentralize care.
Q1: How has PM-JAY improved cancer treatment timelines?
Enrolment in AB-PMJAY has increased the likelihood of initiating cancer treatment within 30 days of diagnosis by approximately 90% compared to pre-2018 levels.
Q2: What is the proposed 'revolving ceiling' for cancer care?
The FinCan study suggests a five-year revolving ceiling of Rs 25 lakh per family. This allows patients to use more funds in high-cost years while ensuring continuity of care.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The FinCan study highlights the need for expanded Ayushman Bharat cancer coverage, focusing on early diagnosis and revised financial ceilings for patients....
4 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today